This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
The company is a pharmaceutical giant with many parts moving in different directions. Some of its blockbusters are losing market exclusivity, but it's also developing plenty of new drugs to take their place. Despite a productive development pipeline and a remarkable track record, shares of Pfizer offer a great big 6% dividend yield at recent prices. Here's why it's a great stock for income-seeking investors to buy now and hold for the long run. Not as bad as it looks At a glance, Pfizer's first-quarter results look awful. Revenue sank by 19% year over year at constant-currency rates. Such a big drop looks like a red flag but it's not as bad as it seems. Sales of Comirnaty, Pfizer's COVID-19 vaccine, and Paxlovid, its antiviral treatment, fell much faster than expected. If we exclude the company's COVID-19 product sales, though, total revenue actually rose by 11% year over year. Now that sales of Pfizer's COVID-19 products have fallen to just 16% of total revenue, their conti
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- BIO to restructure, lay off staff in shakeup of lobbying group [Yahoo! Finance]Yahoo! Finance
- Octapharma USA Appoints Biopharma Industry Veteran Kelly Hearn Vice President of Commercial Marketing & Development [Yahoo! Finance]Yahoo! Finance
- Pfizer wins cancer drug patent case against AstraZeneca [Yahoo! Finance]Yahoo! Finance
- Dow Jones Futures Due; Nvidia Offers Huge Test With 5 AI Stocks Near Buy Points [Yahoo! Finance]Yahoo! Finance
- Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their Lead? [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 5/16/24 - Form 4
- 5/16/24 - Form 4
- 5/9/24 - Form S-8
- PFE's page on the SEC website